PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(04): 35-38
DOI: 10.1055/s-0041-1733096
Case Report

5-Fluorouracil Cardio Toxicity-Revisited

Autoren

  • Rajeshwar Singh

    Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, Chennai, 600020, India

  • TG Sagar

    Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, Chennai, 600020, India

  • SG Ramanan

    Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, Chennai, 600020, India
Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints
Preview Container


Publikationsverlauf

Artikel online veröffentlicht:
28. März 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Roth A, Kolari C, Popovic S. Cardiotoxicity of 5-FU. Cancer Chemother Rep 1975;59:1051-1062
  • 2 DL Keefe, N Roistacher, MK Pierri: Clinical cardiotoxicity of 5-fluorouracil. J Clin Pharmacology 1993;33: 060-1070.
  • 3 RG Dent, I McColl: 5 Fluorouracil and angina. Lancet 1975;1:347-348
  • 4 A Pottage, S Holt, S Ludgate, AO Langlands. Fluorouracil cardiotoxicity. Br Med J 1978;1:547
  • 5 DL Stevenson, DP Mikhailaidis, DS Gillet: Cardiotoxicity of 5 fluorouracil. Lancet 1977;2:406-407
  • 6 Robben NC, Pippas AW, Moore JO. The syndrome of 5- fluorouracil cardiotoxicity. An elusive cardiomyopathy. Cancer 1993;71:493–509
  • 7 JF Ensley, B Patel, R Kloner, JA Kish, J Wynne, M Al- Sarraf: The clinical syndrome of 5-fluorouracil cardiotoxicity. Invest New Drugs 1989;7:101-9.
  • 8 RJ Luwaert, O Descamps, F Majois, JM Chaudron, M Beauduin: Coronary artery spasm induced by 5- fluorouracil. Eur Heart J 1991;12:468-470.
  • 9 NS Kleiman, DE Lehane, CE Geyer, CM Pratt, JB Young: Prinzmetal’s angina during 5-fluorouracil chemotherapy. Am J Med 1987;82:566-568.
  • 10 Y Mizuno, Y Hokamura, T Kimura, Y Kimura, K Kaikita, H Yasue. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction. Jpn Circ J 1995;59:303-307
  • 11 K Becker, JF Erckenbrecht, D Haussinger, T Frieling: Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999;57:475-484.
  • 12 Kinhult S, Albertsson M, Eskilsson J, Cwikiel M. Antithrombic treatment in protection against thrombogenic effects of 5FU on vascular endothelium. Scanning. Jan-Feb 2001;23:(1):1-8.
  • 13 T.Sudhoff, M.D Enderle, M Pahlke, C Petz: 5Fluorouracil induces arterial vasoconstrictions. Annals of Oncology 2004;15:661-664.